Pax4 acts as a key player in pancreas development and plasticity.

Semin Cell Dev Biol

Inserm U1091, CNRS U7277, IBV, Diabetes Genetics Team, FR-06108 Nice, France; Université de Nice-Sophia Antipolis, Laboratoire de Génétique du Développement Normal et Pathologique, FR-06108 Nice, France. Electronic address:

Published: August 2015

The embryonic development of the pancreas is orchestrated by a complex and coordinated transcription factor network. Neurogenin3 (Neurog3) initiates the endocrine program by activating the expression of additional transcription factors driving survival, proliferation, maturation and lineage allocation of endocrine precursors. Among the direct targets of Neurog3, Pax4 appears as one of the key regulators of β-cell specification. Indeed, mice lacking Pax4 die a few days postpartum, as they develop severe hyperglycemia due to the absence of mature pancreatic β-cells. Pax4 also directly regulates the expression of Arx, a gene that plays a crucial role in α-cell specification. Comparative analysis of Pax4 and Arx mutants, as well as Arx/Pax4 double mutants, showed that islet subtype destiny is mainly directed by cross-repression of the Pax4 and Arx factors. Importantly, the ectopic expression of Pax4 in α-cells was found sufficient to induce their neogenesis and conversion into β-like cells, not only during development but also in adult rodents. Therefore, differentiated endocrine α-cells can be considered as a putative source for insulin-producing β-like cells. These findings have clearly widened our understanding regarding pancreatic development, but they also open new research avenues in the context of diabetes research.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcdb.2015.08.013DOI Listing

Publication Analysis

Top Keywords

pax4 arx
8
β-like cells
8
pax4
7
pax4 acts
4
acts key
4
key player
4
player pancreas
4
development
4
pancreas development
4
development plasticity
4

Similar Publications

Oral glucose-responsive nanoparticles loaded with artemisinin induce pancreatic β-cell regeneration for the treatment of type 2 diabetes.

J Colloid Interface Sci

January 2025

School of Life Science, South China Normal University, Guangzhou 510631 China; Guangzhou Key Laboratory of Spectral Analysis and Functional Probes, College of Biophotonics, South China Normal University, Guangzhou 510631 China; South China Normal University-Panyu Central Hospital Joint Laboratory of Translational Medical Research, Panyu Central Hospital, Guangzhou 511400 China. Electronic address:

Type 2 diabetes (T2D) is a chronic disease characterized by long-term insulin resistance (IR) and pancreatic β-cell dysfunction. Conventional T2D medication ignores pancreatic β-cell damage. In this study, we designed an oral glucose-responsive nanoparticle for pancreatic β-cell regeneration and treatment of T2D.

View Article and Find Full Text PDF
Article Synopsis
  • This study focuses on Hesperidin (HES), a key component of the Chinese herbal remedy FoShou, and its potential to regenerate damaged pancreatic β-cells in diabetic mice through the transdifferentiation of α-cells into β-cells.
  • A diabetic mouse model was created using a high-sugar and high-fat diet along with STZ treatment, and after 28 days of HES administration, researchers examined changes in β-cell growth, cell death, and the mechanisms behind cellular transformation.
  • The results suggested that HES could effectively promote the regeneration of β-cells by reprogramming α-cells, but the specific mechanisms of this process remain to be fully elucidated
View Article and Find Full Text PDF

Pancreatic β-cell failure is a pathological feature in type 1 diabetes. One promising approach involves inducing transdifferentiation of related pancreatic cell types, specifically α cells that produce glucagon. The chemokine stromal cell-derived factor-1 alpha (SDF-1α) is implicated in pancreatic α-to-β like cell transition.

View Article and Find Full Text PDF

Differentiation of PANC-1 ductal cells to β-like cells via cellular GABA modulation by Magainin and CPF-7 peptides.

Biochem Biophys Res Commun

March 2022

Institute of Biochemistry and Biophysics, P. O. Box, 13145-1384, University of Tehran, Tehran, Iran. Electronic address:

Some of the antimicrobial peptides induce insulin release and improve glucose tolerance while their effects on pancreatic cell differentiation have remained unresolved. In this report, we evaluated the effects of two of these peptides, Magainin-II and CPF-7, and also GABA, on PANC-1 ductal cells' differentiation. Based on immunofluorescence and qRT-PCR analyses the expression levels of some of the Epithelial to Mesenchymal transition (EMT)-related factors such as Snai1 and Ngn3, as two biomarkers of alpha and beta cells, were increased.

View Article and Find Full Text PDF

Artemether and aspterric acid induce pancreatic alpha cells to transdifferentiate into beta cells in zebrafish.

Br J Pharmacol

May 2022

Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiamen University, Xiamen, China.

Background And Purpose: Recently, the antimalarial drug, artemether and the neurotransmitter GABA were identified to convert alpha cells into beta-like cells in vivo. However, some of these observations were challenged by other studies. To help address the controversy, we took advantage of zebrafish as a model to perform this study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!